REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,369,366 | $71,308,000 | 4.56% |
| Evolutionary Tree Capital Management, LLC | 248,533 | $4,056,000 | 1.95% |
| Essex Woodlands Management, Inc. | 457,085 | $7,460,000 | 1.68% |
| HealthCor Management, L.P. | 1,449,835 | $23,661,000 | 1.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,113,945 | $18,180,000 | 0.64% |
| AlphaCentric Advisors LLC | 65,000 | $1,061,000 | 0.31% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 129,384 | $2,112,000 | 0.24% |
| Antara Capital LP | 250,000 | $4,080,000 | 0.20% |
| Walleye Capital LLC | 357,237 | $5,830,000 | 0.18% |
| Antara Capital LP | 200,000 | $3,264,000 | 0.16% |